Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer

EARLY_PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 25, 2021

Primary Completion Date

November 1, 2024

Study Completion Date

January 31, 2026

Conditions

Recurrent Ovarian CancerPlatinum-sensitive Ovarian Cancer

Interventions

DRUG

Simvastatin 40mg

Simvastatin 40mg by mouth nightly for approximately 6 months during treatment with carboplatin and liposomal doxorubicin

Trial Locations (1)

Cedars Sinai Medical Center, Los Angeles

All Listed Sponsors

lead

Marc Goodman

OTHER